Administration of miR-34a inhibitor was also effectively reduced lung inflammation, as evident by diminished MPO activity in lung intra-alveolar and bronchus area of ALI (IT) mice (Figure 3A–C). The gene discussed is MPO; the disease is acute respiratory distress syndrome.